These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3893275)

  • 41. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
    Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
    Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The leftward deletion alpha-thal-2 haplotype in a black subject with hemoglobin SS.
    Embury SH; Gholson MA; Gillette P; Rieder RF
    Blood; 1985 Mar; 65(3):769-71. PubMed ID: 3971048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical pathophysiology of sickle cell disease.
    Embury SH
    Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical and biological aspects of beta-thalassemia. Apropos of 176 cases].
    Belhani M; Dahmane M; Richard F; Trabuchet G; Benabadji M; Colonna P; Labie D
    Sem Hop; 1977 Apr; 53(16):891-7. PubMed ID: 197608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of homozygous sickle cell disease in northern Greece and Jamaica.
    Christakis J; Vavatsi N; Hassapopoulou H; Papadopoulou M; Mandraveli K; Loukopoulos D; Morris JS; Serjeant BE; Serjeant GR
    Lancet; 1990 Mar; 335(8690):637-40. PubMed ID: 1690325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease.
    Ballas SK
    Pediatr Pathol Mol Med; 2001; 20(2):107-21. PubMed ID: 12673836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting therapeutic efficacy for sickle cell anemia.
    Noguchi CT; Rodgers GP; Serjeant G; Schechter AN
    Prog Clin Biol Res; 1987; 251():497-505. PubMed ID: 3432275
    [No Abstract]   [Full Text] [Related]  

  • 48. Hemoglobin SC disease and alpha-thalassemia. Prolonged survival and mild clinical course.
    Rodgers GP; Sahovic EA; Pierce LE; Anagnou NP; Noguchi CT; Schechter AN
    Am J Med; 1986 Apr; 80(4):746-50. PubMed ID: 3963052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sickle cell/β-thalassemia: Comparison of Sβ
    Benites BD; Bastos SO; Baldanzi G; Dos Santos AO; Ramos CD; Costa FF; Gilli SC; Saad ST
    Hematology; 2016 Dec; 21(10):623-629. PubMed ID: 27237196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leg ulcers in patients with sickle cell disease.
    Koshy M; Entsuah R; Koranda A; Kraus AP; Johnson R; Bellvue R; Flournoy-Gill Z; Levy P
    Blood; 1989 Sep; 74(4):1403-8. PubMed ID: 2475188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.
    Labie D; Pagnier J; Lapoumeroulie C; Rouabhi F; Dunda-Belkhodja O; Chardin P; Beldjord C; Wajcman H; Fabry ME; Nagel RL
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2111-4. PubMed ID: 2580306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of the -alpha 3.7 thalassemia deletion in the non-white Cuban population.
    Martinez G; Ferreira R; Hernandez A; Di Rienzo A; Felicetti L; Colombo B
    Gene Geogr; 1990 Aug; 4(2):65-9. PubMed ID: 2101253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The possible role of genetic modifiers in the clinical severity of sickle cell syndromes.
    Piomelli S
    Ann N Y Acad Sci; 1989; 565():207-10. PubMed ID: 2774424
    [No Abstract]   [Full Text] [Related]  

  • 54. The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia.
    Ballas SK; Talacki CA; Rao VM; Steiner RM
    Hemoglobin; 1989; 13(7-8):649-55. PubMed ID: 2634666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coinheritance of α-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia.
    Belisário AR; Rodrigues CV; Martins ML; Silva CM; Viana MB
    Hemoglobin; 2010; 34(6):516-29. PubMed ID: 21077759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The percentage of dense red cells does not predict incidence of sickle cell painful crisis.
    Billett HH; Kim K; Fabry ME; Nagel RL
    Blood; 1986 Jul; 68(1):301-3. PubMed ID: 3719102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterozygous thalassemia and pregnancy: a twenty-five year experience.
    Morrison JC; Roe PL; Stahl RL; Whybrew WD; Bucovaz ET; Wiser WL; Kraus AP; Fish SA
    J Reprod Med; 1973 Jul; 11(1):35-9. PubMed ID: 4717612
    [No Abstract]   [Full Text] [Related]  

  • 58. The clinical severity of hemoglobin S/Black (
    Cancio MI; Aygun B; Chui DHK; Rothman JA; Scott JP; Estepp JH; Hankins JS
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sickle cell anemia and fetal hemoglobin.
    Steinberg MH
    Am J Med Sci; 1994 Nov; 308(5):259-65. PubMed ID: 7526687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.